Roberto Alonzi

East and North Hertfordshire NHS Trust

Papers

1

Total Citations

1

H-Index

1

About

Roberto Alonzi is a dedicated urologic oncologist whose research focuses on advancing the surgical and post-operative management of prostate cancer, particularly in complex and high-risk cases. His work centers on refining treatment strategies for patients with locally advanced disease, such as pT3b prostate cancer with seminal vesicle invasion, a challenging scenario following robotic-assisted laparoscopic prostatectomy. Alonzi’s major contributions include evaluating the critical role of margin status in guiding adjuvant therapies—such as radiotherapy or salvage approaches—to improve oncologic outcomes while minimizing overtreatment. His single-center experience on managing pT3b disease provides valuable real-world data that helps clinicians navigate treatment dilemmas in this nuanced patient population. Though his most cited paper currently holds 1 citation, it reflects an emerging focus on personalized, evidence-based decision-making in prostate cancer care. Alonzi’s work underscores the importance of integrating surgical expertise with tailored post-operative management, offering practical insights for urologists and oncologists. His research contributes to the growing body of knowledge aimed at optimizing outcomes for men with aggressive prostate cancer, making him a promising voice in the field of urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Single tertiary cancer center experience on the management of pT3b prostate cancer after robotic-assisted laparoscopic prostatectomy
1 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: East and North Hertfordshire NHS Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago